PAD4 inhibition impacts immune responses in SARS-CoV-2 infection. Caio Santos Bonilha
Mucosal Immunol. 2025 Apr 19:S1933-0219(25)00044-3. doi: 10.1016/j.mucimm.2025.04.006. Online ahead of print. ABSTRACT Protein arginine deiminase 4 (PAD4) has emerged as a potential therapeutic target for various diseases due to its role in promoting neutrophil extracellular trap (NET) formation. NETs, composed of DNA and antimicrobial proteins, serve as a defense mechanism against pathogens but can also … Read more